Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $22,707.36 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 29,112 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The shares were bought at an average price of $0.78 per share, with a total value of $22,707.36. Following the purchase, the chief executive officer now owns 15,006,863 shares in the company, valued at $11,705,353.14. This represents a 0.19 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Retractable Technologies Price Performance

NYSE RVP opened at $0.79 on Friday. Retractable Technologies, Inc. has a 1 year low of $0.56 and a 1 year high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company has a fifty day simple moving average of $0.67 and a 200 day simple moving average of $0.83.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Retractable Technologies in a research report on Wednesday. They set a “hold” rating for the company.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.